Gelesis
Biotechnology Research • 
Boston, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 501 Boylston St, Suite 6102, Boston, MA 02116, US |
| Phone number | +16174564718 |
| Website | |
| SIC | 873 |
| Keywords | Diabetes, Medical Devices, Obesity |
| Founded | 2006 |
| Employees | 51-100 |
| Socials |
Key Contacts at Gelesis
Mendy Axlerad
Director, Member Of Bod, Co Founder
Carla Melcarne
Senior Director Qa
Francesco Marotta
Production Director
Gelesis Email Formats
Gelesis uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@gelesis.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@gelesis.com | 50% |
{first name}{last name} | johndoe@gelesis.com | 50% |
About Gelesis
We take our cues from nature to mimic the physical properties of vegetables. We’re developing biomimetic hydrogel therapies for obesity and other chronic metabolic diseases. In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity®, as an aid for weight management in overweight and obese adults with a Body Mass Index (BMI) of 25-40 kg/m², when used in conjunction with diet and exercise. Plenity is contraindicated in patients who are pregnant or are allergic to cellulose, citric acid, sodium stearyl fumarate, gelatin, or titanium dioxide. The most common side effects were diarrhea, distended abdomen, infrequent bowel movements, and flatulence. Plenity is currently available in limited release in the U.S. Gelesis’ proprietary approach inspired to structurally mimic vegetables is designed to act mechanically in the GI pathway to potentially alter the course of certain chronic diseases. In addition to Plenity, Gelesis is developing additional investigational candidates such as Gelesis200, a hydrogel optimized for weight loss and glycemic control in patients with type 2 diabetes and prediabetes. This biomimetic hydrogel based on the Gelesis platform technology are also being advanced in other GI inflammatory conditions, such as non-alcoholic steatohepatitis (NASH) and functional constipation. Community guidelines: http://bit.ly/2Q8VfUG
Gelesis revenue & valuation
| Annual revenue | $12,200,000 |
| Revenue per employee | $213,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $38,900,000 |
| Total funding | $100,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Gelesis has 23 employees across 7 departments.
Departments
Number of employees
Gelesis Tech Stack
Discover the technologies and tools that power Gelesis's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Page builders
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
Video players
Customer data platform
United Kingdom
Canada
Frequently asked questions
4.8
40,000 users
